|
1
|
Shaham O, Menuchin Y, Farhy C and
Ashery-Padan R: Pax6: a multi-level regulator of ocular
development. Prog Retin Eye Res. 31:351–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gosmain Y, Cheyssac C, Heddad Masson M,
Dibner C and Philippe J: Glucagon gene expression in the endocrine
pancreas: the role of the transcription factor Pax6 in alpha-cell
differentiation, glucagon biosynthesis and secretion. Diabetes Obes
Metab. 13(Suppl 1): 31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie Q, Yang Y, Huang J, et al: Pax6
interactions with chromatin and identification of its novel direct
target genes in lens and forebrain. PLoS One. 8:e545072013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mayes DA, Hu Y, Teng Y, et al: PAX6
suppresses the invasiveness of glioblastoma cells and the
expression of the matrix metalloproteinase-2 gene. Cancer Res.
66:9809–9817. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou YH, Tan F, Hess KR and Yung WK: The
expression of PAX6, PTEN, vascular endothelial growth factor, and
epidermal growth factor receptor in gliomas: relationship to tumor
grade and survival. Clin Cancer Res. 9:3369–3375. 2003.PubMed/NCBI
|
|
6
|
Stewart LA: Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu VF, Yang J, Lebrun DG and Li M:
Understanding the role of cytokines in Glioblastoma Multiforme
pathogenesis. Cancer Lett. 316:139–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sathornsumetee S, Reardon DA, Desjardins
A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted
therapy for malignant glioma. Cancer. 110:13–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pulkkanen KJ and Yla-Herttuala S: Gene
therapy for malignant glioma: current clinical status. Mol Ther.
12:585–598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nikaki A, Piperi C and Papavassiliou AG:
Role of microRNAs in gliomagenesis: targeting miRNAs in
glioblastoma multiforme therapy. Expert Opin Investig Drugs.
21:1475–1488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ling N, Gu J, Lei Z, et al: microRNA-155
regulates cell proliferation and invasion by targeting FOXO3a in
glioma. Oncol Rep. 30:2111–2118. 2013.PubMed/NCBI
|
|
13
|
Lin L, Chen X, Peng X, et al: MicroRNA-128
promotes cell-cell adhesion in U87 glioma cells via regulation of
EphB2. Oncol Rep. 30:1239–48. 2013.PubMed/NCBI
|
|
14
|
Wang Y, Zhao W and Fu Q: miR-335
suppresses migration and invasion by targeting ROCK1 in
osteosarcoma cells. Mol Cell Biochem. 384:105–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong M, Ma J, Guillemette R, et al:
miR-335 inhibits small cell lung cancer bone metastases via IGF-1R
and RANKL pathways. Mol Cancer Res. Aug 21–2013.(Epub ahead of
print).
|
|
16
|
Walter BA, Valera VA, Pinto PA and Merino
MJ: Comprehensive microRNA profiling of prostate cancer. J Cancer.
4:350–357. 2013. View
Article : Google Scholar
|
|
17
|
Cao J, Cai J, Huang D, et al: miR-335
represents an invasion suppressor gene in ovarian cancer by
targeting Bcl-w. Oncol Rep. 30:701–706. 2013.PubMed/NCBI
|
|
18
|
Xiong SW, Lin TX, Xu KW, et al:
MicroRNA-335 acts as a candidate tumor suppressor in prostate
cancer. Pathol Oncol Res. 19:529–537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Mao Q, Liu Y, Hao X, Zhang S and
Zhang J: Analysis of miR-205 and miR-155 expression in the blood of
breast cancer patients. Chin J Cancer Res. 25:46–54.
2013.PubMed/NCBI
|
|
20
|
Dohi O, Yasui K, Gen Y, et al: Epigenetic
silencing of miR-335 and its host gene MEST in hepatocellular
carcinoma. Int J Oncol. 42:411–418. 2013.PubMed/NCBI
|
|
21
|
Shi L, Jiang D, Sun G, et al: miR-335
promotes cell proliferation by directly targeting Rb1 in
meningiomas. J Neurooncol. 110:155–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan Z, Xiong Y, Xu W, et al:
Identification of hsa-miR-335 as a prognostic signature in gastric
cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang J, Sun X, Wang W, et al: Tumor
microRNA-335 expression is associated with poor prognosis in human
glioma. Med Oncol. 29:3472–3477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaoka T and Itakura M: Development of
pancreatic islets (review). Int J Mol Med. 3:247–261. 1999.
|
|
25
|
Liu RZ, Monckton EA and Godbout R:
Regulation of the FABP7 gene by PAX6 in malignant glioma cells.
Biochem Biophys Res Commun. 422:482–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou YH, Wu X, Tan F, et al: PAX6
suppresses growth of human glioblastoma cells. J Neurooncol.
71:223–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shu M, Zheng X, Wu S, et al: Targeting
oncogenic miR-335 inhibits growth and invasion of malignant
astrocytoma cells. Mol Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shu M, Zhou Y, Zhu W, et al: MicroRNA 335
is required for differentiation of malignant glioma cells induced
by activation of cAMP/protein kinase A pathway. Mol Pharmacol.
81:292–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaspi H, Chapnik E, Levy M, Beck G,
Hornstein E and Soen Y: Brief report: miR-290–295 regulate
embryonic stem cell differentiation propensities by repressing
Pax6. Stem Cells. 31:2266–2272. 2013.PubMed/NCBI
|
|
30
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen KC, Hsi E, Hu CY, Chou WW, Liang CL
and Juo SH: MicroRNA-328 may influence myopia development by
mediating the PAX6 gene. Invest Ophthalmol Vis Sci. 53:2732–2739.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and
Wu LX: microRNA-223 promotes the growth and invasion of
glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep.
30:2263–2269. 2013.PubMed/NCBI
|
|
33
|
Levicar N, Nuttall RK and Lah TT:
Proteases in brain tumour progression. Acta Neurochir (Wien).
145:825–838. 2003. View Article : Google Scholar : PubMed/NCBI
|
